title: [Remicade in therapy of rheumatoid arthritis and Crohn diseases--no reason for panic].
authors.affiliation: Medizinische Klinik III mit Poliklinik Universitätsklinikum und Institut für Klinische Immunologie, Friedrich-Alexander-Universität Erlangen-Nürnberg.
authors.forename: J R
authors.initials: JR
authors.lastname: Kalden
authors.forename: H
authors.initials: H
authors.lastname: Lochs
authors.forename: H
authors.initials: H
authors.lastname: Wollheim
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D002423:Cause of Death; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D017277:Drug Approval / Q000331:legislation & jurisprudence; D005858:Germany; D006801:Humans; D000069285:Infliximab; D009894:Opportunistic Infections / Q000139:chemically induced / Q000276:immunology / Q000401:mortality; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab